3-MeO-PCP

Current official national law expressly controls 3-MeO-PCP in United States; unauthorized possession, supply, or manufacture is prohibited.

3-MeO-PCP is covered by broad drug analogue laws at both federal and state levels. As PCP is a Schedule 9 prohibited substance, 3-MeO-PCP is similarly prohibited as a structural analogue.⁶

The official RIS consolidated PDF expressly names 3-MeO-PCP in Annex IV.1.

Under Canada's national law, 3-MeO-PCP is controlled; unauthorized possession, supply, or manufacture is prohibited.

Chile controls 3-MeO-PCP because it is named directly in Article 1 of Decreto 867. Article 1 is the severe-effects category referenced by Article 1 of Ley 20.000. Under Ley 20.000 Article 1, unauthorized manufacture, fabrication, transformation, preparation or extraction of Article 1 substances carries presidio mayor in its minimum to medium degrees and a fine of 40 to 400 UTM; Article 3 applies those penalties to trafficking and defines trafficking to include unauthorized import, export, transport, acquisition, transfer, removal, possession, supply, keeping or carrying. Article 4 provides a separate small-quantity offence (presidio menor in its medium to maximum degrees and 10 to 40 UTM) unless the person proves medical treatment or exclusive and proximate personal use; the 23 May 2026 amendment adds that a regulation-designated small quantity capable of grave toxic effects receives the Article 1 penalty, while its transitional note gives the Ministry of Public Security six months to amend Decreto 867 for that new classification. Article 5 separately penalizes non-consensual administration (presidio menor medium to maximum and 11 to 20 UTM; violence or intimidation raises this to presidio mayor minimum to medium), Article 6 penalizes medically unnecessary prescribing of Article 1 substances with presidio mayor minimum to medium and 40 to 400 UTM, and Article 7 penalizes an authorized supplier who breaches governing rules with the same Article 1 range and fine, with possible temporary or definitive closure.

Became a scheduled substance effective October 1, 2015 under Government Decree no. 243/2015 Coll.,¹⁴ which amended Government Regulation no. 463/2013 Coll.citation needed

The 2026 consolidated order's list-B control and general prohibition provisions apply to the named isomer.

German law expressly controls 3-MeO-PCP; unauthorized possession, supply, or manufacture is prohibited.

Listed as a Schedule I controlled substance under Italian drug legislation.¹⁷ Possession, production, and distribution are prohibited.citation needed

Listed as a Schedule I controlled substance under the Dutch Opium Act.¹⁸ Possession, production, and distribution are prohibited.citation needed

The current official Table II-A expressly lists 3-Metoxifenciclina with the matching 3-methoxyphenyl-cyclohexyl-piperidine structure, while listing Fenciclidina or PCP separately; the classification therefore rests on the exact named 3-MeO-PCP entry, not on an inference that it is a PCP salt or isomer. Under current Decreto-Lei n.º 15/93 Article 21(1), unauthorised cultivation, production, sale, distribution, transport, import, export or illicit detention of a Table I-III substance outside Article 40 is punishable by 4-12 years' imprisonment. Article 25 provides 1-5 years for trafficking of Table I-III, V or VI substances when the unlawfulness is considerably diminished. For this Table II-A substance, Article 40(1) makes cultivation for own consumption punishable by up to 3 months' imprisonment or up to 30 days' fine; Article 40(2)-(4) makes acquisition or detention for own consumption a contraordenação, treats more than the average 10-day amount only as an indication that the purpose may not be consumption, and requires archiving, non-indictment or acquittal with referral to the dissuasion commission when exclusive own use is proved. Lei n.º 30/2000 Article 1(2) limits that personal-use regime to substances in Tables I-IV; Article 16(1) states the Table II-A coima as 5,000$00 to a maximum equivalent to the national minimum wage, while Article 17 permits non-pecuniary alternatives.

The consolidated regulation includes amendments through HSLF-FS 2026:26 and lists 3-MeO-PCP with its chemical identity.

The same regulation defines controlled substances as those in its annexes and identifies Verzeichnis d as the relevant controlled schedule.

As of 28 August 2026, 3-MeO-PCP is prohibited in Turkey. The official Turkish Narkotik 2014 report identifies Decision No. 2013/5742, its 16 December 2013 date, publication on 25 January 2014 in Official Gazette No. 28893, and states that 113 new psychoactive substances were made subject to Law No. 2313; its Annex 2 item 110 gives ‘MeO-PCP’ as 1-[1-(3-methoxyphenyl)cyclohexyl]-piperidine, while item 111 separately gives the 4-methoxyphenyl isomer. NIH PubChem independently resolves 3-MeO-PCP/3-methoxyphencyclidine to CID 11778080, IUPAC name 1-[1-(3-methoxyphenyl)cyclohexyl]piperidine, formula C18H27NO, molecular weight 273.4 and CAS 72242-03-6. The current official Narkotik Suçlarla Mücadele Başkanlığı page describes the continuing EWS process for bringing necessary NPS under Law No. 2313 and the generic-classification system. The official 2025 Türkiye Uyuşturucu Raporu states that 1,078 NPS had been brought under Law No. 2313 from 2008 through 31 July 2025 and that 453 were brought in through generic classification; it also identifies Law No. 2313 and TCK Articles 188, 190 and 191 as the principal framework. Current Ministry of Justice TCK text provides Article 188(1)'s 20–30 years' imprisonment and 2,000–20,000 days' judicial fine for unauthorized manufacture/import/export; Article 188(3)'s at-least-10-years' imprisonment and 1,000–20,000 days' judicial fine for listed domestic trafficking/possession conduct; Article 188(6)'s extension to qualifying narcotic- or stimulant-effect substances; and Article 191(1)'s 2–5 years' imprisonment for personal-use purchase, acceptance, possession or use, with the postponement and probation/treatment rules in paragraphs (2)–(3). The Article 188(4)(a) enhancement for specified synthetic-cannabinoid, synthetic-cathinone, synthetic-opioid or amphetamine derivatives is not attributed to 3-MeO-PCP merely from its PCP/arylcyclohexylamine identity. No broader analogue or generic-structure inference is needed because the 3-methoxy chemical name is expressly listed.

Current official national law expressly controls 3-MeO-PCP in United Kingdom; unauthorized possession, supply, or manufacture is prohibited.

Added to Portaria SVS/MS nº 344 on May 17, 2018.⁸ Possession, distribution, and use are prohibited.citation needed